Latest Strategy News

Global X Management (AUS) Limited is trimming the management fee for its Australia 300 ETF (ASX: A300) by 25%, effective 1 July 2026, reflecting a subtle but meaningful cost saving for investors.

Enlitic has landed its inaugural Australian Ensight subscription contract with Lumus Imaging, marking a strategic entry into the local SaaS market and expanding its footprint in diagnostic imaging workflows.

Recce Pharmaceuticals has received a significant A$3.7 million income tax refund from the Australian Taxation Office, strengthening its cash position to approximately A$33.1 million as it prepares for critical Phase 3 clinical milestones.

AdAlta has met a key US$1 million milestone payment under its China collaboration, gaining critical clinical data and securing proprietary materials for Australian manufacturing of its lead CAR-T therapy BZDS1901.

Algorae Pharmaceuticals has clinched a multi-year public hospital supply contract with NSW Health, marking a significant commercial milestone. The rollout is set to begin in the fourth quarter of 2026, underpinning the company's growth ambitions in the Australian healthcare market.

Australian Oil Company (ASX:AOK) has kicked off Phase 1 development in Queensland's Surat Oil Basin, completing well interventions at Emu Apple-1 and revising plans for Riverslea-3 to boost production and exploration.

IperionX has won up to US$6.6 million from the US Department of War to scale production of ballistic-grade titanium plate and military components, aiming to reduce reliance on imports and strengthen domestic supply chains.

Memphasys has locked in a three-year exclusive distribution agreement for its Felix™ sperm separation system in Thailand, targeting a key IVF market with 110 clinics and 20,000–30,000 cycles annually. The deal adds approximately A$430,500 in contracted revenue, lifting South-East Asian minimum contracts to about A$1 million and contributing to FY2026 Felix™ sales now exceeding A$3 million.

The ACCC has rejected Coles’ plan to acquire a leasehold for a new supermarket and liquor store in Kalgoorlie-Boulder, citing risks of reduced competition and the potential exit of an independent rival.

Ampol has finalized its $1.165 billion acquisition of EG Australia, adding around 480 sites and 4,200 employees to its retail footprint. The deal is expected to deliver $65-80 million in synergies and boost earnings per share.

Koba Resources’ recent IP survey at the Stannex Prospect reveals robust chargeability anomalies aligned with high-grade tin mineralisation, setting the stage for an imminent 3,000m drilling campaign.

Dyno Nobel has finalised the sale of its Phosphate Hill fertiliser business to Ryowa, marking a strategic exit from fertilisers and a sharper focus on explosives.